| 4 | Adoption of the Annual Accounts for Calendar Year 2024 | For |
| 5 | Advisory Vote on the Remuneration Report 2024 | Oppose |
| 7 | Adoption of the dividend for 2025 | For |
| 8 | Discharge from liability of the Managing Directors for the performance of their duties during Calendar Year 2024 | For |
| 9 | Discharge from liability of the Supervisory Directors for the performance of their duties during Calendar Year 2024 | For |
| 10a | Re-Elect Metin Colpan - Non-Executive Director | Oppose |
| 10b | Re-Elect Toralf Haag - Non-Executive Director | For |
| 10c | Re-Elect Ross L. Levine - Non-Executive Director | For |
| 10d | Re-Elect Eva Pisa - Non-Executive Director | Oppose |
| 10e | Re-Elect Stephen H. Rusckowski - Non-Executive Director | For |
| 10f | Re-Elect Elizabeth E. Tallett - Non-Executive Director | Oppose |
| 10g | Re-Elect Bert van Meurs - Non-Executive Director | For |
| 10h | Re-Elect Eva van Pelt - Non-Executive Director | For |
| 11a | Reappointment of the Managing Director: Mr. Thierry Bernard | For |
| 11b | Reappointment of the Managing Director: Mr. Roland Sackers | For |
| 12 | Adoption of the Remuneration Policy with respect to the Managing Board | Oppose |
| 13a | Issue a number of ordinary shares and financing preference shares and grant rights to subscribe for such shares, the aggregate par value | For |
| 13b | Restrict or exclude the pre-emptive rights with respect to issuing ordinary shares or granting subscription rights, the aggregate par value of such shares | For |
| 14 | Authorization of the Managing Board, until December 26, 2026, to acquire shares in the Company's own share capital | Oppose |
| 15 | Discretionary Capital Repayment via Synthetic Share Repurchase | Oppose |
| 16 | Cancellation of fractional ordinary shares held by the Company | For |
